Search Results - "van Doorn, M."

Refine Results
  1. 1
  2. 2

    Sustained efficacy of secukinumab in patients with moderate‐to‐severe palmoplantar psoriasis: 2·5‐year results from GESTURE, a randomized, double‐blind, placebo‐controlled trial by Gottlieb, A.B., Kubanov, A., Doorn, M., Sullivan, J., Papp, K.A., You, R., Regnault, P., Frueh, J.A.

    Published in British journal of dermatology (1951) (01-04-2020)
    “…Summary Background Secukinumab has shown sustained efficacy and safety in several manifestations of psoriasis. Objectives GESTURE investigated the long‐term…”
    Get full text
    Journal Article
  3. 3

    A systematic literature review of the human skin microbiome as biomarker for dermatological drug development by Niemeyer ‐ van der Kolk, T., Wall, H. E. C., Balmforth, C., Van Doorn, M. B. A., Rissmann, R.

    Published in British journal of clinical pharmacology (01-10-2018)
    “…Aims To explore the potential of the skin microbiome as biomarker in six dermatological conditions: atopic dermatitis (AD), acne vulgaris (AV), psoriasis…”
    Get full text
    Journal Article
  4. 4

    Visualizing the trigeminovagal complex in the human medulla by combining ex-vivo ultra-high resolution structural MRI and polarized light imaging microscopy by Henssen, D. J. H. A., Derks, B., van Doorn, M., Verhoogt, N. C., Staats, P., Vissers, K., Van Cappellen van Walsum, A. M.

    Published in Scientific reports (05-08-2019)
    “…A trigeminovagal complex, as described in some animals, could help to explain the effect of vagus nerve stimulation as a treatment for headache disorders…”
    Get full text
    Journal Article
  5. 5

    Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision by de Vries, K., Greveling, K., Prens, L.M., Munte, K., Koljenović, S., van Doorn, M.B.A., Prens, E.P.

    Published in British journal of dermatology (1951) (01-03-2016)
    “…Summary Background Lentigo maligna is a slowly growing melanoma in situ. Current guidelines advise wide local excision with a margin of 5 mm as the treatment…”
    Get full text
    Journal Article
  6. 6

    Dietary heme alters microbiota and mucosa of mouse colon without functional changes in host-microbe cross-talk by IJssennagger, Noortje, Derrien, Muriel, van Doorn, Gerdien M, Rijnierse, Anneke, van den Bogert, Bartholomeus, Müller, Michael, Dekker, Jan, Kleerebezem, Michiel, van der Meer, Roelof

    Published in PloS one (11-12-2012)
    “…Colon cancer is a major cause of cancer deaths in Western countries and is associated with diets high in red meat. Heme, the iron-porphyrin pigment of red…”
    Get full text
    Journal Article
  7. 7

    Safety culture in long-term care: a cross-sectional analysis of the Safety Attitudes Questionnaire in nursing and residential homes in the Netherlands by Buljac-Samardzic, Martina, van Wijngaarden, Jeroen Dh, Dekker-van Doorn, Connie M

    Published in BMJ quality & safety (01-06-2016)
    “…The first objective was to investigate if the Safety Attitudes Questionnaire (SAQ) is appropriate to measure the safety attitude of caregivers in nursing and…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Clinical relevance of immunogenicity of biologics in psoriasis: Implications for treatment strategies by Carrascosa, J.-M., van Doorn, M.B.A., Lahfa, M., Nestle, F.O., Jullien, D., Prinz, J.C.

    “…Biological drugs such as the tumour necrosis factor inhibitors have revolutionized the treatment of psoriasis, but some have the potential to induce an…”
    Get full text
    Journal Article
  12. 12

    Telemonitoring to improve nutritional status in community-dwelling elderly: design and methods for process and effect evaluation of a non-randomized controlled trial by van Doorn-van Atten, M N, Haveman-Nies, A, Pilichowski, P, Roca, R, de Vries, J H M, de Groot, C P G M

    Published in BMC geriatrics (16-11-2018)
    “…A good nutritional status is key for maintaining health and quality of life in older adults. In the Netherlands, 11 to 35% of the community-dwelling elderly…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers by Vossen, A.R.J.V., van der Zee, H.H., Davelaar, N., Mus, A.M.C., van Doorn, M.B.A., Prens, E.P.

    “…Background Treatment with apremilast has recently demonstrated clinically meaningful improvement in moderate hidradenitis suppurativa (HS). Objective To…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Non‐invasive anaesthetic methods for dermatological laser procedures: a systematic review by Greveling, K., Prens, E.P., Liu, L., Doorn, M.B.A.

    “…Pain is a common side‐effect of dermatological laser procedures. Non‐invasive anaesthetic drugs and anaesthetic procedures can be used to provide pain relief…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Water- and Air-Distributed Conidia Differ in Sterol Content and Cytoplasmic Microviscosity by Van Leeuwen, M.R, Van Doorn, T.M, Golovina, E.A, Stark, J, Dijksterhuis, J

    Published in Applied and Environmental Microbiology (01-01-2010)
    “…Airborne and waterborne fungal spores were compared with respect to cytoplasmic viscosity and the presence of ergosterol. These parameters differed markedly…”
    Get full text
    Journal Article
  19. 19

    Lentigo maligna – anatomic location as a potential risk factor for recurrences after non‐surgical treatment by Greveling, K., Klok, Th, Doorn, M.B.A., Noordhoek Hegt, V., Prens, E.P.

    “…Background A higher incidence of lentigo maligna (LM) recurrences on the nose was previously observed in our cohort after non‐surgical treatment. Objectives To…”
    Get full text
    Journal Article
  20. 20

    A 5-year natural history study in LAMA2-related muscular dystrophy and SELENON-related myopathy: the Extended LAST STRONG study by de Laat, E C M, Houwen-van Opstal, S L S, Bouman, K, van Doorn, J L M, Cameron, D, van Alfen, N, Dittrich, A T M, Kamsteeg, E J, Smeets, H J M, Groothuis, J T, Erasmus, C E, Voermans, N C, Voermans, Nicol C

    Published in BMC neurology (23-10-2024)
    “…SELENON-related myopathy (SELENON-RM) is a rare congenital myopathy characterized by slowly progressive axial muscle weakness, rigidity of the spine,…”
    Get full text
    Journal Article